Sarkar, S., Kumari, D., Gupta, S. K., Sharma, V., Mukhi, S., Kamboj, P., . . . Dikshit, M. (2021). Saroglitazar and Hepano treatment offers protection against high fat high fructose diet induced obesity, insulin resistance and steatosis by modulating various class of hepatic and circulating lipids. Elsevier.
Cita Chicago Style (17a ed.)Sarkar, Soumalya, et al. Saroglitazar and Hepano Treatment Offers Protection Against High Fat High Fructose Diet Induced Obesity, Insulin Resistance and Steatosis by Modulating Various Class of Hepatic and Circulating Lipids. Elsevier, 2021.
Cita MLA (8a ed.)Sarkar, Soumalya, et al. Saroglitazar and Hepano Treatment Offers Protection Against High Fat High Fructose Diet Induced Obesity, Insulin Resistance and Steatosis by Modulating Various Class of Hepatic and Circulating Lipids. Elsevier, 2021.